1-8 of 8
Anna Teschemaker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Real-World Comparative Analysis of Hypertension and Time to Treatment Failure with Acalabrutinib Vs Ibrutinib in Treatment-Naïve Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Daniel A. Ermann, George Dranitsaris, Sibel Blau, Aaron Peevyhouse, Heather Neuhalfen, Alan SM Yong, Tina K. Wahlstrom, Samantha L. Thompson, Anna Teschemaker, Vikram Shetty, Mayur S. Narkhede
Journal: Blood
Blood (2024) 144 (Supplement 1): 6367.
https://doi.org/10.1182/blood-2024-210396
Published: 2024
Journal Articles

Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment in Patients with Relapsed/Refractory Mantle Cell Lymphoma

Krish Patel, Anna Teschemaker, Hongping Tian, Nick Pyrih, Geert Kolvenbag, Shweta Patel, Svea K. Wahlstrom, Lianzhou Cui
Journal: Blood
Blood (2024) 144 (Supplement 1): 7744.
https://doi.org/10.1182/blood-2024-194523
Published: 2024
Journal Articles

Real-World Risk of Major Bleeding Events in BTKi-Treated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL)

Javid J. Moslehi, Svea K. Wahlstrom, Anna Teschemaker, Rachel H. Mackey, Diana DeVincenzo, Leslie A. Carabuena, Samantha L. Thompson, Brittaney-Belle Elizabeth Gordon, Ning A. Rosenthal
Journal: Blood
Blood (2024) 144 (Supplement 1): 5109.
https://doi.org/10.1182/blood-2024-198681
Published: 2024
Journal Articles

Real-World Bleeding Risk, Outcomes and Treatment Patterns of Patients with CLL/SLL Receiving BTKi with or without Prescription Anticoagulants or Antiplatelets

Brittaney-Belle Elizabeth Gordon, Svea K. Wahlstrom, Anna Teschemaker, Rachel H. Mackey, Diana DeVincenzo, Leslie A. Carabuena, Samantha L. Thompson, Ning A. Rosenthal, Javid J. Moslehi
Journal: Blood
Blood (2024) 144 (Supplement 1): 5105.
https://doi.org/10.1182/blood-2024-198724
Published: 2024
Journal Articles

Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment By Line of Therapy in Patients with Chronic Lymphocytic Leukemia and/or Small Lymphocytic Lymphoma

Ryan W Jacobs, Anna Teschemaker, Shweta Hakre, Hongping Tian, Nick Pyrih, Svea K. Wahlstrom, Lianzhou Cui
Journal: Blood
Blood (2023) 142 (Supplement 1): 5151.
https://doi.org/10.1182/blood-2023-174974
Published: 2023
Journal Articles

Patient and Physician Preferences for Fixed-Duration Vs Treatment to Progression Chronic Lymphocytic Leukemia (CLL) Treatments: Results from a Multi-Country Discrete Choice Experiment

Bersabeh Sile, Dahbia Horchi, Bleuenn Rault, Emily Mulvihill, Kathleen Beusterien, Anna Teschemaker, Katherine Stewart, Paulo Andre P. Palhares De Miranda, Xavier Guillaume
Journal: Blood
Blood (2023) 142 (Supplement 1): 6528.
https://doi.org/10.1182/blood-2023-177690
Published: 2023
Journal Articles

Real World Comparison of Bruton Tyrosine Kinase Inhibitors and Venetoclax in Patients Diagnosed with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Lindsey E. Roeker, Yi Han, Kellie J. Ryan, Anna Teschemaker, Anthony R. Mato
Journal: Blood
Blood (2022) 140 (Supplement 1): 7025–7027.
https://doi.org/10.1182/blood-2022-163534
Published: 2022
Journal Articles

Myeloid/Lymphoid Neoplasms (MLNs) with Fibroblast Growth Factor Receptor 1 ( FGFR1 ) Rearrangement (MLN FGFR1 ): A US Real-World Retrospective Cohort Study

Shreekant Parasuraman, Anna Teschemaker, Jonathan K. Kish, Kristin M. Savill, Philomena Colucci
Journal: Blood
Blood (2022) 140 (Supplement 1): 6854–6855.
https://doi.org/10.1182/blood-2022-162320
Published: 2022